[Video] Biotech Financing Environment and Deal Considerations
Against the backdrop of a prolonged global pandemic, international conflict and a shifting economic climate, the capital markets landscape is ever-changing. Cooley brings you a quarterly webinar series that cuts through the noise and drills down on what you need to know about the current market.
Our inaugural webinar focuses on the current biotech financing environment and deal considerations. Cooley's David Peinsipp and Rich Segal, and Morgan Stanley's Kalli Dircks, managing director of healthcare equity capital markets, provide key insights on financing under current market conditions, including the alternative financing structures companies have been turning to and practical considerations in navigating them.